HIV-1 entry inhibitors: new targets, novel therapies
- 18 October 2002
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 85 (2) , 113-118
- https://doi.org/10.1016/s0165-2478(02)00235-3
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary InfectionJournal of Virology, 2002
- Potential New Therapies for the Treatment of HIV-1 InfectionAnnual Review of Medicine, 2002
- DC-SIGN and DC-SIGNR: helping hands for HIVTrends in Immunology, 2001
- HIV chemotherapyNature, 2001
- HIV-1 Drug Resistance in Newly Infected IndividualsJAMA, 1999
- Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV InfectionJAMA, 1999
- Transmission of antiretroviral-drug-resistant HIV-1 variantsThe Lancet, 1999
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984